The efficacy of indirect KRAS inhibition is also limited by other cancer-related cellular processes, such as cell Warburg metabolism, a process in which cancer cells preferentially use glycolysis to consume glucose and generate lactate despite the presence of oxygen; this process can be triggered by the mutant KRAS protein and maintain tumor growth 29. The gene discussed is KRAS; the disease is neoplasm.